Webster Financial Corporation

- No specific new fundraising through debt or equity is mentioned. - The company notes seasonality in borrowing, including redemption of sub-debt notes and some temporary elevation in long-term debt. - Current debt sits slightly over $1.1 billion but has been reduced to $650 million after redemptions. - Seasonality impacts include $1.2 billion of public funds leaving and expected to flow back. - No unusual or new debt issuances planned; movements are tied to seasonality and ongoing management of existing liabilities. - The company is focused on maintaining strong capital ratios above well-capitalized levels and is contemplating reducing its CET1 capital target after stress testing in upcoming quarters. - Share repurchases are expected to continue, with an emphasis on remaining capital efficient. - Overall, no indication of immediate plans for new debt or equity fundraising in the near term.

- Continued investments in technology to support direct-to-consumer growth, particularly for the HSA business, focusing on client experience and new investment options. - No further technology buildout required for incremental deposit growth related to the new bill-driven HSA expansion; current infrastructure is scalable at no additional cost. - Marketing and client outreach investments mainly target the "bronze opportunity," focusing on identifying and educating potential direct-to-consumer HSA clients. - Expenses include investments linked to growth opportunities at HSA Bank and expanded technology capabilities. - Strategic capital allocation includes tuck-in acquisitions to enhance and supplement healthcare verticals and deposit gathering capabilities. - Anticipation of Category 4 regulatory changes may allow for reallocation or reduction of some planned expenses, giving more flexibility in investments.

- Loan growth is projected at 5% to 7% for full year 2026, with diverse growth across commercial loan categories including commercial real estate. - Deposit growth forecasted at 4% to 6%, with expectations for incremental $1 billion to $2.5 billion growth in HSA deposits over the next five years, including $50 million to $100 million in 2026. - Continued strong growth anticipated from the Ametros business with mid-20% growth rates expected. - Revenue expected around $3 billion for 2026, including net interest income between $2.57 billion and $2.63 billion. - Fee income projected between $390 million and $410 million, with variability driven by client activity and direct investment gains. - Investments in technology and marketing, especially for HSA growth via direct-to-consumer channels, support expansion. - NIM expected to hold steady at approximately 3.35% through 2026, supporting stable revenue.

- Earnings per share (EPS) increased 10% over the prior year, indicating strong profitability growth in 2025. - For full-year 2026, management expects loan growth of 5% to 7% and deposit growth of 4% to 6%, supporting revenue expansion. - Net interest income (NII) for 2026 is guided between $2.57 billion and $2.63 billion, assuming significant Fed rate cuts in June and September. - Fee income is forecasted between $390 million and $410 million, with variability driven by volatility in categories like BOLI and direct investments. - Expenses for 2026 are expected between $1.46 billion and $1.48 billion, with a slight increase in Q1 due to seasonal factors but stable thereafter. - The outlook reflects deliberate capital allocation and profitable growth, with the bank aiming to outgrow and outearn the industry sustainably.

The provided document excerpts do not contain specific information regarding current, expected order book, or pending orders. The content primarily focuses on: - Loan growth outlook and deposit growth for 2026. - Growth in Health Savings Accounts (HSA) and related infrastructure. - Acquisition of SecureSave and its integration. - Deposit competition and pricing dynamics. - Credit quality and portfolio risk. - Capital management and share repurchase plans. - Fee income drivers and expense trends. No details or figures related to order books or pending orders are mentioned in these pages. If you have other specific pages or sections related to order management or sales pipeline, please provide them for a more targeted response.